Serum RARRES2 Is a Prognostic Marker in Patients With Adrenocortical Carcinoma (Q41010316)
Jump to navigation
Jump to search
scientific article published on 23 June 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Serum RARRES2 Is a Prognostic Marker in Patients With Adrenocortical Carcinoma |
scientific article published on 23 June 2016 |
Statements
1 reference
Serum RARRES2 Is a Prognostic Marker in Patients With Adrenocortical Carcinoma (English)
1 reference
Yi Liu-Chittenden
Kelli Gaskins
23 June 2016
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference